Form 4 Tracker
Dennis Podlesak

Director · 1 filing · Latest: Feb 4, 2026

Syndax Pharmaceuticals Inc
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
SNDX
DENNIS G PODLESAKAug 18, 2025
Proposed Sale
$15.7414,400$226.7K
SNDX
DENNIS G PODLESAKAug 14, 2025
Proposed Sale
$13.4543,200$581.0K